Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Francisco Lopez-Munoz"'
Autor:
Francisco López-Muñoz, Cecilio Alamo
Publikováno v:
Current Pharmaceutical Design. 15:1559-1562
Publikováno v:
Taiwanese Journal of Psychiatry, Vol 36, Iss 3, Pp 103-110 (2022)
Background: The figure of Luis Simarro Lacabra is not well-known outside Spain, but within the country became a character of special scientific and public importance. Luis Simarro, a person of a marked progressist spirit, not only was involved from h
Externí odkaz:
https://doaj.org/article/4be891577e4442a98324f08f18d5f389
Autor:
Francisco Lopez-Munoz
Publikováno v:
Taiwanese Journal of Psychiatry, Vol 35, Iss 3, Pp 103-116 (2021)
Background: Miguel de Cervantes (1547–1617) was a Spanish writer, who has often been considered as the greatest writer in the Spanish language and one of the world's outstanding novelists. His novel Don Quixote, is a work often cited as both the fi
Externí odkaz:
https://doaj.org/article/a80b797c4e4e4968844cc0e3f0e6ab07
Autor:
Alamo, Cecilio, Lopez-Munoz, Francisco
Publikováno v:
Current Pharmaceutical Design; May 2009, Vol. 15 Issue: 14 p1559-1562, 4p
Autor:
Francisco Lopez-Munoz
Publikováno v:
Taiwanese Journal of Psychiatry, Vol 34, Iss 3, Pp 147-147 (2020)
Externí odkaz:
https://doaj.org/article/9c328fb0e3e840f98d7ce2810d452773
Autor:
Francisco Lopez-Munoz
Publikováno v:
Asian Journal of Biomedical and Pharmaceutical Sciences. 10
As we know that COVID-19 is a transferable disease initiated by a newly discovered virus called corona virus. This cause fever and common cold to more severe diseases called Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syn
Autor:
Francisco López-Muñoz, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, Takahiro A. Kato
This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms unde
Autor:
Francisco Lopez-Munoz, Cecilio Alamo
Major depressive disorders have recently been associated with impairments in signaling pathways that regulate neuroplasticity and cell survival. Agents designed to directly target molecules in these pathways hold promise as new therapeutics for depre
Publikováno v:
Frontiers in Neuroscience; 2024, p1-15, 15p
Publikováno v:
Frontiers in Pharmacology; 2024, p1-9, 9p